NASDAQ:KRYS
Krystal Biotech, Inc.
- Stock
Last Close
163.19
16/05 20:00
Market Cap
4.68B
Beta: 0.85
Volume Today
159.41K
Avg: 203.48K
PE Ratio
−105.15
PFCF: −26.48
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | 3.49M - | ||||||||
average payables | 117.50K - | 540.50K 360% | 806K 49.12% | 1.41M 75.50% | 5.25M 271.26% | 6.19M 17.86% | 4.06M 34.46% | ||
average receivables | 21.02M - | ||||||||
book value per share | 0.07 - | 9.23 13,553.79% | 10.11 9.51% | 12.76 26.26% | 15.55 21.83% | 26.74 72.00% | 20.49 23.39% | 0.03 99.86% | |
capex per share | -0.00 - | -0.04 1,016.61% | -0.20 409.02% | -0.40 101.81% | -0.79 96.32% | -3.08 289.67% | -2.08 32.49% | -0.00 99.98% | |
capex to depreciation | -7.50 - | -9.13 21.74% | -15.84 73.53% | -8.55 46.01% | -8.02 6.26% | -24.68 207.76% | -13.07 47.06% | -2.36 81.96% | |
capex to operating cash flow | 0.01 - | 0.05 371.83% | 0.24 338.14% | 0.34 44.57% | 0.57 66.42% | 1.43 150.50% | 0.53 63.05% | 0.13 74.78% | |
capex to revenue | -2.18 - | -0.23 - | |||||||
cash per share | 0.45 - | 9.25 1,956.83% | 9.98 7.83% | 12.18 22.10% | 14.44 18.54% | 19.74 36.69% | 14.87 24.64% | 0.02 99.87% | |
days of inventory on hand | |||||||||
days payables outstanding | |||||||||
days sales outstanding | 302.66 - | ||||||||
debt to assets | 0.84 - | 0.02 - | 0.04 138.01% | 0.01 65.51% | 0.02 24.85% | 0.00 88.74% | |||
debt to equity | 6.38 - | 0.02 - | 0.04 145.90% | 0.01 65.80% | 0.02 26.54% | 0.00 88.93% | |||
dividend yield | |||||||||
earnings yield | -0.03 - | -0.14 455.56% | -0.05 66.70% | -0.02 53.66% | -0.03 31.65% | -0.04 57.02% | -0.07 54.69% | 0.00 100.00% | |
enterprise value | 45.41M - | 6.80M 85.02% | 129.13M 1,798.46% | 696.35M 439.26% | 870.51M 25.01% | 1.22B 40.08% | 1.87B 53.06% | 3.44T 184,339.13% | |
enterprise value over ebitda | -39.80 - | -1.43 96.40% | -10.97 665.67% | -32.64 197.65% | -27.95 14.38% | -18.67 33.19% | -16.83 9.88% | -31.37K 186,344.43% | |
ev to operating cash flow | -34.64 - | -1.75 94.95% | -13.67 681.90% | -37.21 172.18% | -33.37 10.31% | -25.44 23.78% | -18.56 27.04% | -38.77K 208,774.13% | |
ev to sales | 125.74 - | 67.90K - | |||||||
free cash flow per share | -0.31 - | -0.76 146.61% | -1.04 36.30% | -1.58 51.49% | -2.18 37.94% | -5.24 140.47% | -6.02 14.99% | -0.00 99.94% | |
free cash flow yield | -0.03 - | -0.07 149.43% | -0.05 31.00% | -0.03 43.16% | -0.04 27.32% | -0.07 106.26% | -0.08 1.53% | -0.00 99.96% | |
graham net net | 0.01 - | 9.13 130,041.09% | 9.72 6.42% | 11.80 21.39% | 13.44 13.93% | 18.26 35.88% | 13.45 26.33% | 0.02 99.86% | |
graham number | 0.64 - | 17.52 2,638.59% | 14.87 15.12% | 18.57 24.88% | 24.47 31.82% | 43.43 77.44% | 50.31 15.85% | 0.02 99.97% | |
income quality | 1.14 - | 0.49 56.92% | 0.87 76.60% | 0.98 13.02% | 0.81 17.29% | 0.69 15.02% | 0.72 4.27% | -8.12 1,230.63% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -163.29 - | -1.52 99.07% | -11.60 665.41% | -45.76 - | -27.81 39.23% | ||||
interest debt per share | 0.43 - | 0.59 35.72% | 0.09 84.39% | 0.21 123.78% | 0.61 199.58% | 0.43 30.24% | 0.56 29.51% | 0.00 99.99% | |
inventory turnover | |||||||||
invested capital | 6.38 - | 0.02 - | 0.04 145.90% | 0.01 65.80% | 0.02 26.54% | 0.00 88.93% | |||
market cap | 45.49M - | 56.39M 23.97% | 232.80M 312.82% | 880.60M 278.27% | 1.13B 28.01% | 1.55B 37.74% | 2.02B 30.06% | 3.44T 170,386.14% | |
net current asset value | 276K - | 49.27M 17,752.90% | 109.76M 122.75% | 189.77M 72.90% | 256.30M 35.06% | 409.55M 59.79% | 347.56M 15.14% | 548.20M 57.73% | |
net debt to ebitda | 0.07 - | 10.44 14,793.49% | 8.80 15.69% | 8.64 1.90% | 8.24 4.57% | 5.10 38.09% | 1.38 72.97% | 3.25 135.82% | |
net income per share | -0.27 - | -1.48 449.29% | -0.97 34.21% | -1.20 23.50% | -1.71 42.63% | -3.13 83.05% | -5.49 75.19% | 0.00 100.01% | |
operating cash flow per share | -0.31 - | -0.73 136.66% | -0.84 16.18% | -1.18 39.59% | -1.39 17.97% | -2.16 55.56% | -3.95 82.67% | -0.00 99.92% | |
payables turnover | |||||||||
receivables turnover | 1.21 - | ||||||||
research and ddevelopement to revenue | 7.56 - | 0.92 - | |||||||
return on tangible assets | -0.53 - | -0.16 70.01% | -0.09 40.66% | -0.09 2.62% | -0.10 13.32% | -0.11 7.34% | -0.25 125.64% | 0.01 105.33% | |
revenue per share | 0.09 - | 0.00 - | |||||||
roe | -3.98 - | -0.16 95.98% | -0.10 39.93% | -0.09 2.18% | -0.11 17.07% | -0.12 6.42% | -0.27 128.69% | 0.01 105.24% | |
roic | -0.54 - | -0.10 82.01% | -0.11 9.11% | -0.11 0.18% | -0.10 0.69% | -0.11 6.97% | -0.27 140.04% | -0.16 39.82% | |
sales general and administrative to revenue | 4.05 - | ||||||||
shareholders equity per share | 0.07 - | 9.23 13,553.79% | 10.11 9.51% | 12.76 26.26% | 15.55 21.83% | 26.74 72.00% | 20.49 23.39% | 0.03 99.86% | |
stock based compensation to revenue | 0.77 - | 0.79 - | |||||||
tangible asset value | 289K - | 49.47M 17,019.03% | 113.23M 128.86% | 202.91M 79.21% | 292.08M 43.94% | 593.58M 103.22% | 522.23M 12.02% | 778.64M 49.10% | |
tangible book value per share | 0.07 - | 9.23 13,553.79% | 10.11 9.51% | 12.76 26.26% | 15.55 21.83% | 26.74 72.00% | 20.49 23.39% | 0.03 99.86% | |
working capital | 2.13M - | 49.27M 2,217.69% | 110.05M 123.35% | 192.55M 74.96% | 259.61M 34.82% | 416.53M 60.45% | 354.93M 14.79% | 554.82M 56.32% |
All numbers in USD (except ratios and percentages)